Epitomee Medical Ltd

ILA 304.80As of Sun 8 Nov 2026, 12:00 UTC
TASE:EPITHealthcare
Country Israel
PE (Fwd) •••
TSR 5Y CAGR (38.23%)
Div yield —
ROE (37.92%)
Medical Devices
Beta (5Y) 0.48
PE TTM —
TSR TTM (57.95%)
Mkt cap ILS 91.53M
ROIC (19.22%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
ILA 313
2.63%
(92.85%)
Hold 5|3|2|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
2.62
2.88
3.19
3.29
(3.31%)
7.80%
19.75%
24.11%
Revenue$M
4.028
3.911
3.853
3.810
(1.50%)
(6.68%)
(7.65%)
(7.31%)
Peers (US$27.10M)
Cap (US$)
PE
16.45M
—
Capital
TTM
5Y
10Y
Leveragex
1.143
(0.198)
(0.186)
EBIT/Intx
0.193
4.579
4.726
Own earn%
(33.31)
(79.94)
(84.09)
Sh yield%
43.27
35.69
33.76
Owners
Insiders/Inst%
2.06
27.59
Short interest%
4.62
SBC / revenue%
5.59
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
15–22
$1 testx
−0.5
Incr. ROIC%
1